RBM, Luminex, Invitrogen, HUPO, GE Healthcare, Illumina, Type I Diabetes Genetics Consortium, JP Morgan, Agilent, Piper Jaffray, Cepheid, HiFi DNA Tech, Nanosphere | GenomeWeb
RBM to Pay Luminex $12.5M to Settle Dispute, Raises $25M in Private Funding
 
Multiplexed biomarker testing lab Rules Based Medicine will pay Luminex $12.5 million to settle a lawsuit having to do with Biophysical Corporation’s testing services, Luminex said this week.
 
RBM, which was spun off from Luminex in September 2002, initially filed the claims in a Travis County, Texas, District Court in 2005, but Luminex soon afterward responded with its own counterclaims.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.